Legal Representation
Attorney
Bruce W. Longbottom
USPTO Deadlines
Next Deadline
82 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
October 22, 2025
Extension Available
Until October 22, 2025
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 17, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 15, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 14, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 14, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 14, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 22, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 27, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 27, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 7, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 25, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 24, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 24, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 24, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 9, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 9, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 9, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 20, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 28, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 4, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Product development; Pharmaceutical products development; Biological product development services; Research and development services in the field of pharmaceutical preparations; Pharmaceutical drug development services; Scientific research and development; Scientific laboratory services, namely, providing shared wet laboratory facilities and shared laboratory apparatus and instruments as part of the wet laboratory facility usage for others; Research and development of vaccines and medicines; Product research; Laboratory research services relating to pharmaceuticals; Biological research laboratory services; Scientific research consulting; Research and development in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Providing information relating to scientific research in the fields of biochemistry and biotechnology; Research and development in the field of therapeutics.
Additional Information
Design Mark
The mark consists of "LILLY catalyze360" in a stylized font in the color red.
Color Claim
The color(s) red is/are claimed as a feature of the mark.
Pseudo Mark
LILLY CATALYZE THREE HUNDRED SIXTY
Pseudo Mark
LILLY CATALYZE THREE SIX ZERO
Classification
International Classes
042